Regeneron Pharmaceuticals Inc (NAS:REGN)
$ 927.33 -1.28 (-0.14%) Market Cap: 102.22 Bil Enterprise Value: 95.26 Bil PE Ratio: 24.56 PB Ratio: 3.62 GF Score: 96/100

Regeneron Pharmaceuticals Inc Oncology Investor Event at ESMO Transcript

Sep 20, 2021 / 12:30PM GMT
Release Date Price: $640.89 (-1.69%)
Operator

Good day, and thank you for standing by. Welcome to the Regeneron Oncology Investor Event, ESMO 2021. (Operator Instructions) Please be advised today's conference may be recorded. (Operator Instructions) I'd now like to hand the conference over to Justin Holko, Vice President, Investor Relations.

Justin Holko
Regeneron Pharmaceuticals, Inc. - VP of IR

Thank you, Liz, and welcome to everybody to join this call this morning. Joining me on the call today are Dr. George Yancopoulos, Co-Founder, President and Chief Scientific Officer; and Dr. Israel Lowy, Senior Vice President of Transitional Sciences and Oncology. After our prepared remarks, we'll open the call for Q&A.

Before handing the call over to George, however, I would like to remind you that remarks made on today's call include forward-looking statements about Regeneron, including those related to Regeneron's business and research and development programs, anticipated milestones regulatory matters.

Each forward-looking statement is subject to risks and uncertainties that could cause

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot